Also known as: Ginkgo Bioworks, Ginkgo BioWorks
Federated learning models have been shown to outperform all alternatives in drug discovery, while the broader life sciences sector increasingly relies on high-performance computing and AI-ready data infrastructure. These trends are reshaping R&D, with new collaborative approaches and data center demands driving innovation.
Global biologics market projected to grow to USD 1.28 trillion by 2035; Japan cell and gene therapy market to reach USD 2.15 billion by 2034; Japan biologic drug lifecycle management market to hit USD 9.69 billion by 2033.
The mRNA therapy market is forecast to grow from USD 13.6 billion in 2025 to USD 70.0 billion by 2035 at a 17.8% CAGR, driven by expanding applications beyond vaccines into oncology, rare diseases, and infectious disease treatments including genital herpes.
